A historical review of bone marrow transplantation for immunodeficiencies

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 4, 2004, Pages 793-800

  Buckley, Rebecca H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHEDIAK HIGASHI SYNDROME; COMBINED IMMUNODEFICIENCY; DIGEORGE SYNDROME; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE ADHESION DEFICIENCY; MICROENVIRONMENT; OMENN SYNDROME; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; WISKOTT ALDRICH SYNDROME;

EID: 1942531983     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.01.764     Document Type: Review

References (73)

1. Amos DB, Bach FH. Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med 1968;128:623-37.
2. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MD. Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968;2:1364-6.
3. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;2:1366-9.
4. Bortin MM, Rimm AA. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. JAMA 1977;238:591-600.
5. Muller-Ruchholtz W, Wottge HU, Muller-Hermelink HK. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow. Transplant Proc 1976;8:537-41.
6. Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci U S A 1978;75: 2933-6.
7. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;61:341-8.
8. Buckley RH, Schiff SE, Sampson HA, Schiff RI, Marken ML, Knutsen AP, et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986;136:2398-407.
9. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-non-identical T cell depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodef Rev 1989; 1:273-309.
10. Dror Y, Gallagher R, WaraM DW, Colombe BW, Merino A, Benkerrou M, et al. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T cell depleted haplocompatible bone marrow transplantation. Blood 1993;81: 2021-30.
11. Giri N, Vowels M, Ziegler JB, Ford D, Lam-Po-Tang R. HLA non-identical T cell depleted bone marrow transplantation for primary immunodeficiency diseases. Aust N Z J Med 1994;24:26-30.
12. Wijnaendts L, LeDeist F, Griscelli C, Fischer A. Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 1989;74: 2212-9.
13. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, et al. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508-16.
14. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002;99:872-8.
15. Moen RC, Horowitz SD, Sondel PM, Borcherding WR, Trigg ME, Billing R, et al. Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: treatment of bone marrow cells with monoclonal antibody CT-2 and complement. Blood 1987;70:664-9.
16. Patel DD, Gooding ME, Parrott RE, Curtis KM, Haynes BF, Buckley RH. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000;342:1325-32.
17. Schiff SE, Buckley RH. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras. J Immunol 1987;138:2088-94.
18. Roberts JL, Volkman DJ, Buckley RH. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. J Immunol 1989;143:1575-9.
19. Marken ML, Sarzotti M, Ozaki DA, Sempowski GD, Rhein ME, Hale LP, et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 2003;102:1121-30.
20. Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994;83:1149-54.
21. Berthet F, Le Deist F, Duliege AM, Griscelli C, Fischer A. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency). Pediatrics 1994;93: 265-70.
22. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, de Saint-Basile G, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 cases. J Pediatr 1993;123:564-72.
23. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003;361:553-60.
24. Buckley RH, Schiff RI, Schiff SE, Marken ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency (SCID): genetic, phenotypic and functional diversity in 108 infants. J Pediatr 1997;130:378-87.
25. Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T- cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998;91:3646-53.
26. Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A, et al. European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 1990;336:850-4.
27. Lanfranchi A, Verardi R, Tettoni K, Neva A, Mazzolari E, Pennacchio M, et al. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency. Haematologica 2000;85(suppl 11):41-6.
28. Bertrand Y, Landais P, Friedrich W, Gerritsen B, Morgan G, Fasth A, et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical T cell-depleted bone marrow transplantation. J Pediatr 1999;134:740-8.
29. O'Marcaigh AS, DeSantes K, Hu D, Pabst H, Horn B, Li L, et al. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans. Bone Marrow Transplant 2001;27:703-9.
30. Kane L, Gennery AR, Crooks BN, Flood TJ, Abinun M, Cant AJ. Neonatal bone marrow transplantation for severe combined immunodeficiency. Arch Dis Child Fetal Neonatal Ed 2001;85: F110-3.
31. Wengler GS, Lanfranchi A, Frusca T, Verardi R, Neva A, Brugnoni D, et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). Lancet 1996;348:1484-7.
32. Flake AW, Roncarolo MG, Puck JM, Almeida-Porada G, Evans MI, Johnson MP, et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996;335:1806-10.
33. Miano M, Porta F, Locatelli F, Miniero R. La Nasa G, di Bartolomeo P, et al., Unrelated donor marrow transplantation for inborn errors. Bone Marrow Transplant 1998;21(suppl 2):S37-41.
34. Ozsahin H, Le Deist F, Benkerrou M, Cavazzana-Calvo M, Gomez L, Griscelli C, et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 1996;129: 238-44.
35. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001;97:1598-603.
36. Knutsen AP, Wall DA. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. J Allergy Clin Immunol 1999;103:823-32.
37. Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A. Treatment of Omenn syndrome by bone marrow transplantation. J Pediatr 1995;127:76-81.
38. Loechelt BJ, Shapiro RS, Jyonouchi H, Filipovich AH. Mismatched bone marrow transplantation for Omenn syndrome: a variant of severe combined immunodeficiency. Bone Marrow Transplant 1995;16:381-5.
39. LeDeist F, Blanche S, Keable H. Successful HLA non-identical bone marrow transplantation in three patients with leukocyte adhesion deficiency. Blood 1989;74:512.
40. Thomas C, LeDeist F, Cavazzana-Calvo M, Benkerrou M, Haddad E, Blanche S, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 1995;86:1629-35.
41. Canioni D, Patey N, Cuenod B, Benkerrou M, Brousse N. Major histocompatibility complex class II deficiency needs an early diagnosis: report of a case. Pediatr Pathol Lab Med 1997;17:645-51.
42. Klein C, Cavazzana-Calvo M, Le Deist F, Jabado N, Benkerrou M, Blanche S, et al. Bone marrow transplantation in major histocompatibility complex class II deficiency: a single center study of 19 patients. Blood 1995;85:580-7.
43. Casper JT, Ash RA, Kirchner P, Hunter JB, Havens PL, Chusid MJ. Successful treatment with an unrelated donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome"). J Pediatr 1990;116:262-5.
44. Bonduel M, Pozo A, Zelazko M, Raslawski E, Delfino S, Rossi J, et al. Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplant 1999;24:437-40.
45. Fischer A, Durandy A, De Villartay JP, Vilmer E, Le Deist F, Gerota I, et al. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine. Blood 1986;67:444-9.
46. Haddad E, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E, et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995;85:3328-33.
47. Liang JS, Lu MY, Tsai MJ, Lin DT, Lin KH. Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome. J Formos Med Assoc 2000;99: 499-502.
48. Hobbs JR, Monteil M, McCluskey DR, Jurges E, El Tumi M. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr 1992;151:806-10.
49. Kamani N, August CS, Campbell DE, Hassan NF, Douglas SD. Marrow transplantation in chronic granulomatous disease: an update, with 6-year follow up. J Pediatr 1988;113:697-700.
50. di Bartolomeo P, Girolamo G, Angrilli P, Schettini F, De Mattie D, Manzionna MM, et al. Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant 1989;4:695-700.
51. Rappeport JM, Newburger PE, Goldblum RM, Goldman AS, Nathan DG, Parkman R. Allogeneic transplantation for chronic granulomatous disease. J Pediatr 1982;101:952-5..
52. Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001;344:881-8.
53. Ozsahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998;92:2719-24.
54. Seger RA, Ezekowitz RAB. Treatment of chronic granulomatous disease. Immunodeficiency 1994;5:113-30.
55. Nagler A, Ackerstein A, Kapelushnik J, Or R, Naparstek E, Slavin S. Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant 1999;24:339-42.
56. Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, di Bartolomeo P, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 2002;100:4344-50.
57. Goldsobel AB, Haas A, Stiehm ER. Bone marrow transplantation in DiGeorge syndrome. J Pediatr 1987;111:40-4.
58. Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM, Batchvarova MN, et al. Thymus transplantation in complete DiGeorge syndrome. N Engl J Med 1999;341:1180-9.
59. Thomas C, de Saint Basile G, Le Deist F, Theophile D, Benkerrou M, Haddad E, et al. Brief report: correction of X-linked hyper-IgM syndrome by altogeneic bone marrow transplantation. N Engl J Med 1995;333:426-9.
60. Scholl PR, O'Gorman MR, Pachman LM, Haut P, Kletzet M. Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. Bone Marrow Transplant 1998;22:1215-8.
61. Fasth A. Bone marrow transplantation for hyper-IgM syndrome. Immunodeficiency 1993;4:323.
62. Duplantier JE, Seyama K, Day NK, Hitchcock R, Nelson RP Jr, Ochs HD, et al. Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome. Clin Immunol 2001;98:313-8.
63. Khawaja K, Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch Dis Child 2001;84:508-11.
64. Ziegner UH, Ochs HD, Schanen C, Feig SA, Seyama K, Futatani T, et al. Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr 2001;138:570-3.
65. De Santes KB, Lai SS, Cowan MJ. Haploidentical bone marrow transplants for two patients with reticular dysgenesis. Bone Marrow Transplant 1996;17:1171-3.
66. Bertrand Y, Muller SM, Casanova JL, Morgan G, Fischer A, Friedrich W. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transplant 2002; 29:759-62.
67. Broome CB, Graham ML, Saulsbury FT, Hershfield MS, Buckley RH. Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling. J Pediatr 1996;128:373-6.
68. Carpenter PA, Ziegler JB, Vowels MR. Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;17:1214.
69. Williams LL, Rooney CM, Conley ME, Brenner MK, Krance RA, Heslop HE. Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet 1993;342:587-8.
70. Gross TG, Filipovich AH, Conley ME, Pracher E, Schmiegelow K, Verdirame JD, et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996;17:741-4.
71. Pracher E, Panzer-Grumayer ER, Zoubek A, Peters C, Gadner H. Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant 1994;13:655-8.
72. Schneider LC, Berman RS, Shea CR, Perez-Atayde AR, Weinstein H, Geha RS. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome). J Clin Immunol 1990;10:146-53.
73. Benkerrou M, Le Deist F, De Villartay JP, Caillat-Zucman S, Rieux-Laucat F, Jabado N, et al. Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation. Eur J Immunol 1997;27:2043-7.